The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Changes in androgen receptor (AR) expression and its phosphorylated isoforms, in breast cancer (BC) patients treated with neoadjuvant letrozole.
Angel Guerrero
No relevant relationships to disclose
Rachel Ruoff
No relevant relationships to disclose
Joaquin Gavila
No relevant relationships to disclose
Susan Logan
No relevant relationships to disclose
Francisco Gozlabo
No relevant relationships to disclose
Miguel Angel Climent Duran
No relevant relationships to disclose
Vicente Guillem
No relevant relationships to disclose
Franco Muggia
No relevant relationships to disclose
Amparo Ruiz
No relevant relationships to disclose